Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Simplex Virus Infections Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 General Treatment
1.2.3 Antiviral Therapy
1.3 Market by Application
1.3.1 Global Herpes Simplex Virus Infections Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Herpes Simplex Virus Infections Market Perspective (2017-2028)
2.2 Herpes Simplex Virus Infections Growth Trends by Region
2.2.1 Herpes Simplex Virus Infections Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Herpes Simplex Virus Infections Historic Market Size by Region (2017-2022)
2.2.3 Herpes Simplex Virus Infections Forecasted Market Size by Region (2023-2028)
2.3 Herpes Simplex Virus Infections Market Dynamics
2.3.1 Herpes Simplex Virus Infections Industry Trends
2.3.2 Herpes Simplex Virus Infections Market Drivers
2.3.3 Herpes Simplex Virus Infections Market Challenges
2.3.4 Herpes Simplex Virus Infections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Herpes Simplex Virus Infections Players by Revenue
3.1.1 Global Top Herpes Simplex Virus Infections Players by Revenue (2017-2022)
3.1.2 Global Herpes Simplex Virus Infections Revenue Market Share by Players (2017-2022)
3.2 Global Herpes Simplex Virus Infections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Herpes Simplex Virus Infections Revenue
3.4 Global Herpes Simplex Virus Infections Market Concentration Ratio
3.4.1 Global Herpes Simplex Virus Infections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Infections Revenue in 2021
3.5 Herpes Simplex Virus Infections Key Players Head office and Area Served
3.6 Key Players Herpes Simplex Virus Infections Product Solution and Service
3.7 Date of Enter into Herpes Simplex Virus Infections Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Herpes Simplex Virus Infections Breakdown Data by Type
4.1 Global Herpes Simplex Virus Infections Historic Market Size by Type (2017-2022)
4.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Type (2023-2028)
5 Herpes Simplex Virus Infections Breakdown Data by Application
5.1 Global Herpes Simplex Virus Infections Historic Market Size by Application (2017-2022)
5.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Herpes Simplex Virus Infections Market Size (2017-2028)
6.2 North America Herpes Simplex Virus Infections Market Size by Type
6.2.1 North America Herpes Simplex Virus Infections Market Size by Type (2017-2022)
6.2.2 North America Herpes Simplex Virus Infections Market Size by Type (2023-2028)
6.2.3 North America Herpes Simplex Virus Infections Market Share by Type (2017-2028)
6.3 North America Herpes Simplex Virus Infections Market Size by Application
6.3.1 North America Herpes Simplex Virus Infections Market Size by Application (2017-2022)
6.3.2 North America Herpes Simplex Virus Infections Market Size by Application (2023-2028)
6.3.3 North America Herpes Simplex Virus Infections Market Share by Application (2017-2028)
6.4 North America Herpes Simplex Virus Infections Market Size by Country
6.4.1 North America Herpes Simplex Virus Infections Market Size by Country (2017-2022)
6.4.2 North America Herpes Simplex Virus Infections Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Herpes Simplex Virus Infections Market Size (2017-2028)
7.2 Europe Herpes Simplex Virus Infections Market Size by Type
7.2.1 Europe Herpes Simplex Virus Infections Market Size by Type (2017-2022)
7.2.2 Europe Herpes Simplex Virus Infections Market Size by Type (2023-2028)
7.2.3 Europe Herpes Simplex Virus Infections Market Share by Type (2017-2028)
7.3 Europe Herpes Simplex Virus Infections Market Size by Application
7.3.1 Europe Herpes Simplex Virus Infections Market Size by Application (2017-2022)
7.3.2 Europe Herpes Simplex Virus Infections Market Size by Application (2023-2028)
7.3.3 Europe Herpes Simplex Virus Infections Market Share by Application (2017-2028)
7.4 Europe Herpes Simplex Virus Infections Market Size by Country
7.4.1 Europe Herpes Simplex Virus Infections Market Size by Country (2017-2022)
7.4.2 Europe Herpes Simplex Virus Infections Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Herpes Simplex Virus Infections Market Size (2017-2028)
8.2 Asia-Pacific Herpes Simplex Virus Infections Market Size by Type
8.2.1 Asia-Pacific Herpes Simplex Virus Infections Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Herpes Simplex Virus Infections Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Herpes Simplex Virus Infections Market Share by Type (2017-2028)
8.3 Asia-Pacific Herpes Simplex Virus Infections Market Size by Application
8.3.1 Asia-Pacific Herpes Simplex Virus Infections Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Herpes Simplex Virus Infections Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Herpes Simplex Virus Infections Market Share by Application (2017-2028)
8.4 Asia-Pacific Herpes Simplex Virus Infections Market Size by Region
8.4.1 Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Herpes Simplex Virus Infections Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Herpes Simplex Virus Infections Market Size (2017-2028)
9.2 Latin America Herpes Simplex Virus Infections Market Size by Type
9.2.1 Latin America Herpes Simplex Virus Infections Market Size by Type (2017-2022)
9.2.2 Latin America Herpes Simplex Virus Infections Market Size by Type (2023-2028)
9.2.3 Latin America Herpes Simplex Virus Infections Market Share by Type (2017-2028)
9.3 Latin America Herpes Simplex Virus Infections Market Size by Application
9.3.1 Latin America Herpes Simplex Virus Infections Market Size by Application (2017-2022)
9.3.2 Latin America Herpes Simplex Virus Infections Market Size by Application (2023-2028)
9.3.3 Latin America Herpes Simplex Virus Infections Market Share by Application (2017-2028)
9.4 Latin America Herpes Simplex Virus Infections Market Size by Country
9.4.1 Latin America Herpes Simplex Virus Infections Market Size by Country (2017-2022)
9.4.2 Latin America Herpes Simplex Virus Infections Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Herpes Simplex Virus Infections Market Size (2017-2028)
10.2 Middle East & Africa Herpes Simplex Virus Infections Market Size by Type
10.2.1 Middle East & Africa Herpes Simplex Virus Infections Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Herpes Simplex Virus Infections Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Herpes Simplex Virus Infections Market Share by Type (2017-2028)
10.3 Middle East & Africa Herpes Simplex Virus Infections Market Size by Application
10.3.1 Middle East & Africa Herpes Simplex Virus Infections Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Herpes Simplex Virus Infections Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Herpes Simplex Virus Infections Market Share by Application (2017-2028)
10.4 Middle East & Africa Herpes Simplex Virus Infections Market Size by Country
10.4.1 Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Herpes Simplex Virus Infections Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Admedus Limited
11.1.1 Admedus Limited Company Details
11.1.2 Admedus Limited Business Overview
11.1.3 Admedus Limited Herpes Simplex Virus Infections Introduction
11.1.4 Admedus Limited Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.1.5 Admedus Limited Recent Developments
11.2 Agenus Inc.
11.2.1 Agenus Inc. Company Details
11.2.2 Agenus Inc. Business Overview
11.2.3 Agenus Inc. Herpes Simplex Virus Infections Introduction
11.2.4 Agenus Inc. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.2.5 Agenus Inc. Recent Developments
11.3 Aicuris Anti-infective Cures Gmbh
11.3.1 Aicuris Anti-infective Cures Gmbh Company Details
11.3.2 Aicuris Anti-infective Cures Gmbh Business Overview
11.3.3 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Introduction
11.3.4 Aicuris Anti-infective Cures Gmbh Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.3.5 Aicuris Anti-infective Cures Gmbh Recent Developments
11.4 Asahi Kasei Corporation
11.4.1 Asahi Kasei Corporation Company Details
11.4.2 Asahi Kasei Corporation Business Overview
11.4.3 Asahi Kasei Corporation Herpes Simplex Virus Infections Introduction
11.4.4 Asahi Kasei Corporation Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.4.5 Asahi Kasei Corporation Recent Developments
11.5 Chimerix Inc.
11.5.1 Chimerix Inc. Company Details
11.5.2 Chimerix Inc. Business Overview
11.5.3 Chimerix Inc. Herpes Simplex Virus Infections Introduction
11.5.4 Chimerix Inc. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.5.5 Chimerix Inc. Recent Developments
11.6 Clinigen Group Plc
11.6.1 Clinigen Group Plc Company Details
11.6.2 Clinigen Group Plc Business Overview
11.6.3 Clinigen Group Plc Herpes Simplex Virus Infections Introduction
11.6.4 Clinigen Group Plc Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.6.5 Clinigen Group Plc Recent Developments
11.7 Daewoong Pharmaceutical Co., Ltd.
11.7.1 Daewoong Pharmaceutical Co., Ltd. Company Details
11.7.2 Daewoong Pharmaceutical Co., Ltd. Business Overview
11.7.3 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Introduction
11.7.4 Daewoong Pharmaceutical Co., Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.7.5 Daewoong Pharmaceutical Co., Ltd. Recent Developments
11.8 F. Hoffmann-la Roche Ltd.
11.8.1 F. Hoffmann-la Roche Ltd. Company Details
11.8.2 F. Hoffmann-la Roche Ltd. Business Overview
11.8.3 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Introduction
11.8.4 F. Hoffmann-la Roche Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.8.5 F. Hoffmann-la Roche Ltd. Recent Developments
11.9 Glaxosmithkline Plc
11.9.1 Glaxosmithkline Plc Company Details
11.9.2 Glaxosmithkline Plc Business Overview
11.9.3 Glaxosmithkline Plc Herpes Simplex Virus Infections Introduction
11.9.4 Glaxosmithkline Plc Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.9.5 Glaxosmithkline Plc Recent Developments
11.10 Maruho Co. Ltd.
11.10.1 Maruho Co. Ltd. Company Details
11.10.2 Maruho Co. Ltd. Business Overview
11.10.3 Maruho Co. Ltd. Herpes Simplex Virus Infections Introduction
11.10.4 Maruho Co. Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.10.5 Maruho Co. Ltd. Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Herpes Simplex Virus Infections Introduction
11.11.4 Merck Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.11.5 Merck Recent Developments
11.12 Mylan
11.12.1 Mylan Company Details
11.12.2 Mylan Business Overview
11.12.3 Mylan Herpes Simplex Virus Infections Introduction
11.12.4 Mylan Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.12.5 Mylan Recent Developments
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Herpes Simplex Virus Infections Introduction
11.13.4 Novartis Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.13.5 Novartis Recent Developments
11.14 Sanofi Pasteur
11.14.1 Sanofi Pasteur Company Details
11.14.2 Sanofi Pasteur Business Overview
11.14.3 Sanofi Pasteur Herpes Simplex Virus Infections Introduction
11.14.4 Sanofi Pasteur Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.14.5 Sanofi Pasteur Recent Developments
11.15 Teva Pharmaceutical Industries Ltd.
11.15.1 Teva Pharmaceutical Industries Ltd. Company Details
11.15.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.15.3 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Introduction
11.15.4 Teva Pharmaceutical Industries Ltd. Revenue in Herpes Simplex Virus Infections Business (2017-2022)
11.15.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer